Exploring Magnetic and Electrical Brain Stimulation in Parkinsonian Dyskinetic Monkeys
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2025
DOI: 10.1017/cjn.2024.284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2025. Verfasst von Estelle Gouriou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Noninvasive Neurostimulation Laboratory, Neuroscience Unit, Research Center of CHU de Québec - Université Laval, Quebec, Canada. Hauptthemen laut MEDLINE: Parkinsonian Disorders, Transcranial Direct Current Stimulation, Dyskinesia, Drug-Induced, Transcranial Magnetic Stimulation. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Parkinson’s disease (PD) chronic L-Dopa treatment often triggers motor complications, such as L-Dopa-induced dyskinesias (LID). LID are reported to be associated with abnormal glutamatergic activity between the striatum and primary motor cortex (M1), resulting in M1 hyperactivation. Beneficial noninvasive brain stimulation (NIBS) paradigms were reported to normalize glutamatergic activity. The objective of the present study was thus to set up a NIBS paradigm in parkinsonian monkeys to investigate motor behavior under basal conditions and with L-Dopa treatment-inducing dyskinesias.
Methods
Motor behavior was investigated in five 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) dyskinetic female Macaca fascicularis monkey models of PD, allowing us to monitor the administration of NIBS and drugs. NIBS used were inhibitory protocols, that is, cathodal transcranial direct current stimulation (c-tDCS) and continuous theta-burst stimulation (cTBS). A procedure of three weeks was developed to progressively acclimate animals to the experimental conditions, equipment and noise of c-tDCS and cTBS before stimulating them with either vehicle or L-Dopa.
Results
One session of c-tDCS with L-Dopa yielded no effect, whereas five sessions briefly reduced LID but decreased the duration of L-Dopa anti-PD effects. cTBS alone improved (decreased) parkinsonian scores as compared to sham stimulation or vehicle alone. Two sessions of cTBS with L-Dopa decreased LID without affecting L-Dopa anti-PD effects.
Conclusion
This is the first study testing c-tDCS and cTBS on the motor behavior of MPTP dyskinetic monkeys. As compared to medicated patients, MPTP monkeys offer the opportunity to evaluate NIBS after-effects in drug-free and LID conditions, which are critical in the search for new PD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Noninvasive Neurostimulation Laboratory, Neuroscience Unit, Research Center of CHU de Québec - Université Laval, Quebec, Canada.
- Axe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, Canada.
- Faculty of Medicine, Université Laval, Quebec, Canada.
- Faculty of Medicine, School of Rehabilitation Science, Université Laval, Quebec, Canada.
- Faculty of Pharmacy, Université Laval, Quebec, Canada.
ORCID-Profile: Estelle Gouriou, Thérèse Di Paolo
Zitieren
APA
Gouriou, E., Bourque, M., Schneider, C., & Di Paolo, T. (2025). Exploring Magnetic and Electrical Brain Stimulation in Parkinsonian Dyskinetic Monkeys. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/cjn.2024.284
Vancouver
Gouriou E, Bourque M, Schneider C, Di Paolo T. Exploring Magnetic and Electrical Brain Stimulation in Parkinsonian Dyskinetic Monkeys. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2025. doi:10.1017/cjn.2024.284
BibTeX
@article{Gouriou2025,
author = {Gouriou, Estelle and Bourque, Mélanie and Schneider, Cyril and Di Paolo, Thérèse},
title = {Exploring Magnetic and Electrical Brain Stimulation in Parkinsonian Dyskinetic Monkeys},
journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
year = {2025},
doi = {10.1017/cjn.2024.284}
}
EUVIMED